Back
Fate Therapeutics Stock Price Chart
Sponsored
FATE
Sponsored
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.
Sell
34
FATE
Fate Therapeutics
Last Price:
2.81
Seasonality Move:
31.52%
7 Day Trial
ALL ACCESS PASS
$
7
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing selling pressure, which indicates risk of future bearish movement.
Fate Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.13 | Sell |
20-day SMA: | 3.2 | Sell |
50-day SMA: | 3.48 | Sell |
200-day SMA: | 4.69 | Sell |
8-day EMA: | 3.13 | Sell |
20-day EMA: | 3.23 | Sell |
50-day EMA: | 3.48 | Sell |
200-day EMA: | 4.29 | Sell |
Fate Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 39.11 | Sell |
Chaikin Money Flow: | -751726 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.03 - 3.61) | Sell |
Bollinger Bands (100): | (3.13 - 4.31) | Sell |
Fate Therapeutics Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Fate Therapeutics Stock
Is Fate Therapeutics Stock a Buy?
- Fate Therapeutics share price is 3.03 while FATE 8-day simple moving average is 3.13, which is a Sell signal.
- The stock price of FATE is 3.03 while Fate Therapeutics 20-day SMA is 3.20, which makes it a Sell.
- Fate Therapeutics 50-day simple moving average is 3.48 while FATE share price is 3.03, making it a Sell technically.
- FATE stock price is 3.03 and Fate Therapeutics 200-day simple moving average is 4.69, creating a Sell signal.
FATE Technical Analysis vs Fundamental Analysis
Sell
34
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics a Buy or a Sell?
-
Fate Therapeutics stock is rated a Sell
The current Fate Therapeutics [FATE] share price is $3.03. The Score for FATE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Fate Therapeutics Stock Info
Market Cap:
345.05M
Price in USD:
3.03
Share Volume:
1.05M
Fate Therapeutics 52-Week Range
52-Week High:
8.83
52-Week Low:
1.63
Sell
34
Fate Therapeutics (FATE)
is a Sell
Fate Therapeutics Share Price Forecast
-
What is the Fate Therapeutics stock price today?
The Fate Therapeutics stock price is 3.03 USD today. -
Will FATE stock go up or go down?
Fate Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Fate Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fate Therapeutics is overvalued.
Is Fate Therapeutics Stock a Buy?
- Fate Therapeutics share price is 3.03 while FATE 8-day exponential moving average is 3.13, which is a Sell signal.
- The stock price of FATE is 3.03 while Fate Therapeutics 20-day EMA is 3.23, which makes it a Sell.
- Fate Therapeutics 50-day exponential moving average is 3.48 while FATE share price is 3.03, making it a Sell technically.
- FATE stock price is 3.03 and Fate Therapeutics 200-day simple moving average is 4.29, creating a Sell signal.
Fundamental Analysis of Fate Therapeutics
Is Fate Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Fate Therapeutics
Should I short Fate Therapeutics stock?
- FATE Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Fate Therapeutics is a Sell
- Fate Therapeutics Relative Strength Index (RSI) is 39.11, which suggest Fate Therapeutics is oversold
- The Bollinger Bands (25) for Fate Therapeutics is (3.03 - 3.61), which suggest Fate Therapeutics is a Sell
- The Bollinger Bands (100) for Fate Therapeutics is (3.13 - 4.31), which suggest Fate Therapeutics is a Sell
* Fate Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.